|Audit Committee||Compensation Committee||Nominating and Corporate Governance Committee|
|Franklin M. Berger, CFA||Audit Committee||Nominating and Corporate Governance Committee|
|Graham Cooper||Audit Committee||Compensation Committee|
|Jason R. Dinges, Ph.D., J.D.||Nominating and Corporate Governance Committee|
|Elizabeth Garner, MD, MPH||Audit Committee|
|Michael Kauffman, M.D., Ph.D.||Compensation Committee|
|Jean-Pierre Sommadossi, Ph.D.||Compensation Committee||Nominating and Corporate Governance Committee|
Contact the Board
You can contact Kezar’s Board of Directors to provide comments, report concerns, or ask a question, at the following address:
Kezar Life Sciences, Inc.
4000 Shoreline Court, Suite 300
South San Francisco, CA 94080
You may submit your concern anonymously or confidentially by postal mail. You may also indicate whether you are a shareholder, customer, supplier or other interested party.
Communications are distributed to the Board, or to any individual director as appropriate, depending on the facts and circumstances outlined in the communication. In that regard, the Board requests that certain items that are unrelated to the duties and responsibilities of the Board be excluded, such as:
- Product complaints
- Product inquiries
- New product suggestions
- Resumes and other forms of job inquiries
- Business solicitations or advertisements
In addition, material that is unduly hostile, threatening, illegal or similarly unsuitable will be excluded, with the provision that any communication that is filtered out must be made available to any non-management director upon request.